Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MAIA Biotechnology, Inc. Common Stock (NY: MAIA )

2.120 -0.010 (-0.47%)
Official Closing Price Updated: 8:00 PM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MAIA Biotechnology, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
MAIA Biotechnology Announces FDA Clearance of IND Application for THIO, a First-in-Class Telomere Targeting Agent for the Treatment of Non-Small Cell Lung Cancer
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Announces Share Repurchase Program
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Reports Second Quarter 2023 Financial Results and Provides Updates for THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Reports Updates on Disease Control Rates for THIO-101 Phase 2 Trial for Advanced Non-Small Cell Lung Cancer
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Reports Updates on Preliminary Survival Data for THIO-101 Phase 2 Trial for Advanced Non-Small Cell Lung Cancer
From MAIA Biotechnology, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
7 Up-and-Coming Stocks to Buy for the Next Decade
While less-established enterprises are best left for speculators, these up-and-coming stocks to buy also feature huge upside potential. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers 
Via Benzinga
MAIA Biotechnology Announces Updates in Enrollment in Phase II Clinical Trial: THIO-101 Has Enrolled 29 Patients
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Files Second Patent For New Telomere-Targeting Molecules Program
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Reports First Quarter 2023 Financial Results and Provides Corporate Update
From MAIA Biotechnology, Inc.
Via Business Wire
TRACON Pharmaceuticals And 2 Other Stocks Under $3 Insiders Are Aggressively Buying
The Dow Jones closed higher by more than 250 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
MAIA Biotechnology, Inc. Announces Closing of Public Offering
From MAIA Biotechnology, Inc.
Via Business Wire
Nasdaq Down 50 Points; US Home Price Index Rises In February
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.01% to 33,872.34 while the... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Why Aaron's Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Gainers ZeroFox Holdings, Inc. (NASDAQ: ZFOX) gained 36.7% to $1.49 in pre-market trading after dropping around 17% on Monday. ZeroFox completed the acquisition of LookingGlass Cyber Solutions, Inc. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another dive into the biggest pre-market stock movers as we check out the latest news worth watching on Tuesday! 
Via InvestorPlace
MAIA Biotechnology, Inc. Announces Pricing of Public Offering
From MAIA Biotechnology, Inc.
Via Business Wire
GeoVax Labs And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed slighty higher on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny... 
Via Benzinga
MAIA Biotechnology Reports Preliminary Survival Data in Part A of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
From MAIA Biotechnology, Inc.
Via Business Wire
JOANN And 3 Other Stocks Under $4 Insiders Are Aggressively Buying
The Dow Jones closed slightly lower on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny... 
Via Benzinga
MAIA Biotechnology Announces Excellent Efficacy of THIO in Liver Cancer Models
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology to Present at AACR Annual Meeting 2023
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Touts Positive Data From Healthy Volunteer Study Of Potential Lung Cancer Candidate
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
MAIA Biotechnology Reports Positive Topline Data from Part A Safety Lead-In of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Reports Full Year 2022 Financial Results and Provides Corporate Update
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology And 2 Other Stocks Under $5 Insiders Are Aggressively Buying
The Dow Jones closed lower by more than 500 points on Wednesday following Fed’s rate decision. When insiders purchase or sell shares, it indicates their confidence or concern around the company's... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 74 companies achieved new lows for the year. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.